Friday, March 29, 2024

TOPICS

Home Tags Rhode Island Hospital

Tag: Rhode Island Hospital

PBN PHOTO/RUPERT WHITELEY


Most-read stories during November 2017, on PBN.com

1. New sensor technology boosts, expands AVTECH capabilities. PUBLISHED IN PRINT: Sept. 22. Checking the power status of multiple servers in a data center...
RHODE ISLAND HOSPITAL operating room nurses have received the Committed to OR Excellence Award from the Association of periOperative Registered Nurses for excellent perioperative care. / COURTESY LIFESPAN CORP.

Rhode Island Hospital nurses earn clinical excellence award

PROVIDENCE – Rhode Island Hospital’s operating room nursing staff has been recognized by the Association of periOperative Registered Nurses with a Committed to OR...

Management is a service job

Dr. Louis B. Rice | University Medicine Foundation CEO, ­president and physician-in-chief Leading a group of physicians is a complex endeavor that requires honesty and...
LIFESPAN NET ASSETS increased $126.9 million year over year to $1.4 billion for the year ended Sept. 30, 2017.

Lifespan improves operations in FY 2017, generating more cash, paying off...

PROVIDENCE — The Lifespan Corp. nonprofit health system reported $14.6 million of operating income for the fiscal year ending Sept. 30, 2017, in its...
DR. TERRANCE T. HEALEY is director of thoracic radiology at Rhode Island Hospital and chair of the American Lung Association’s LUNG FORCE Expo - Providence. / COURTESY AMERICAN LUNG ASSOCIATION

Five Questions With: Dr. Terrance T. Healey

Dr. Terrance T. Healey, director of thoracic radiology at Rhode Island Hospital and chair of the American Lung Association’s LUNG FORCE Expo - Providence,...
MACHINE PREP: Dr. Ling Zhang, left, and Dr. Gregory D. Jay, owner of Lubris LLC, prepare the AKTA machine to purify antibodies at the Lubris lab. Lubris has licensed the glycoprotein lubricin to Novartis to use as a dry-eye treatment. / PBN PHOTO/
RUPERT WHITELEY

Lifespan researcher scores commercial hit with biolubricant Novartis deal

Dr. Gregory D. Jay, owner of Lubris LLC, is celebrating his company’s licensing of lubricin as a clinically superior dry-eye treatment to Novartis, which...

Rhode Island Hospital wins $8M grant to improve child asthma treatment...

PROVIDENCE — The National Heart, Lung and Blood Institute has awarded a $7,999,307 grant to Rhode Island Hospital to develop a community-based Asthma Care Implementation...
RHODE ISLAND HOSPITAL recently secured a $5.8 million grant for cartilage and joint research. / COURTESY RHODE ISLAND HOSPITAL

Rhode Island Hospital wins $5.8 million COBRE grant for cartilage, joint...

PROVIDENCE — Rhode Island Hospital’s Center of Biomedical Research Excellence for Skeletal Health and Repair has won a $5.8 million, 5-year Phase III COBRE...
AGAINST THE CLOCK: The neuro-interventional team at Rhode Island Hospital finishes performing a thrombectomy procedure on a patient with an acute ischemic stroke. Speeding stroke treatment by minutes can dramatically improve recovery time and results.   / COURTESY RICHARD SCHULTZ

Lifespan perpetually aiming for health care’s horizon

Excellence at an Enterprise Company | Lifespan Corp. Becoming a leader in providing health care and in research has been instrumental in allowing Lifespan Corp....
DR. ROBERT C. WARD is a radiologist at the Anne C. Pappas Center for Breast Imaging and the lead investigator for a clinical trial testing cryoablation cold treatment for breast cancer at Rhode Island Hospital. / COURTESY LIFESPAN CORP.

R.I. Hospital testing cryoablation treatment for breast tumors

PROVIDENCE – Rhode Island Hospital is one of 10 sites in the nation studying the effectiveness of cryoablation – killing cancer cells with extreme...
- Featured Event -

Latest News